PetMETA is a metabolomics test that includes certain well-known clinical chemistry markers as well as a wide range of other metabolites. Many diseases cause widespread metabolic changes in addition to their primary effects. The PetMETA test aims to refine clinical diagnostics and is well suited to complement routine clinical chemistry analyses. The PetMETA test can be used to complement diagnostics of metabolic diseases, to monitor health and to make informed feeding plans. 

 

Creatinine
Albumin 
Sugar metabolism
Glucose
Lactate
Citrate
Inflammation
Glycoprotein acetyls
Cholesterol
Total cholesterol
HDL cholesterol
LDL cholesterol
VLDL cholesterol
Esterified cholesterol
Free cholesterol
Triglycerides
Total triglycerides
HDL triglycerides
LDL triglycerides
VLDL triglycerides
Lipoproteins
Concentration of HDL particles
Total lipids in HDL particles
Diameter of HDL particles
Concentration of LDL particles
Total lipids in LDL particles
Diameter of LDL particles
Concentration of VLDL particles
Total lipids in VLDL particles
Diameter of VLDL particles
Amino Acids
Alanine
Glutamine
Glycine*
Leucine
Isoleucine
Valine
Branched-chain amino acids
Phenylalanine
Phenylalanine / tyrosine
Tyrosine
Fatty acids
Total fatty acids
Polyunsaturated fatty acids (PUFA)
Saturated Fatty Acids (SFA)
Omega-3 Fatty Acids (Omega-3)
Omega-6 Fatty Acids (Omega-6)
Omega-6/Omega-3
Arachidonic Acid (AA)
Linoleic Acid (LA)
Docosahexaenoic acid (DHA)

 

*not quantifiable from EDTA-plasma samples

 

The total number or analyzed biomarkers by the NMR testing panel utilized in PetMETA is over 120. The entire test content, including research phase biomarkers, can be provided on request.

PetMETA is soon commercially available in Finland.